References

Clayman E, Marcet K, Kuykendall L, Atisha D. Pyoderma gangrenosum following bilateral deep inferior epigastric perforator flaps. J Reconstr Microsurg Open. 2016; 01:(02)125-127 https://doi.org/10.1055/s-0036-1592142

Farhi D, Wallach D, Avril MF. Pyoderma gangrenosum is 100 years old. From Louis Brocq to biotherapies. La Revue du praticien. 2008; 58:(4)457-461

Brunsting LA, Goeckerman WH, OLeary PA. Pyoderma gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syph. 1930; 22:655-680 https://doi.org/10.1001/archderm.1930.01440160053009

Vacas AS, Torre AC, Bollea-Garlatti ML Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients. Int J Dermatol. 2017; 56:(4)386-391 https://doi.org/10.1111/ijd.13591

Abdelrahman W, Walsh MY, Hoey SE Pyoderma gangrenosum: a rare cause of cutaneous ulceration and one easily misdiagnosed. Case Rep Pediatr. 2016; 2016

Ruocco E, Sangiuliano S, Gravina AG Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009; 23:(9)1008-1017 https://doi.org/10.1111/j.14683083.2009.03199.x

Su WP, Davis MD, Weenig RH Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004; 43:(11)790-800 https://doi.org/10.1111/j.1365-4632.2004.02128.x

Dhooghe N, Oieni S, Peeters P Post surgical pyoderma gangrenosum in flap surgery: diagnostic clues and treatment recommendations. Acta Chir Belg. 2017; 117:(2)69-76 https://doi.org/10.1080/00015458.2016.1264729

Pereira N, Brites MM, Gonçalo M Pyoderma gangrenosum - a review of 24 cases observed over 10 years. Int J Dermatol. 2013; 52:(8)938-945 https://doi.org/10.1111/j.1365-4632.2011.05451.x

Von Den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997; 137:(6)1000-1005 https://doi.org/10.1046/j.13652133.1997.20022083.x

Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum. Review of 21 cases. Arch Dermatol. 1989; 125:(1)57-64 https://doi.org/10.1001/archderm.1989.01670130059007

Healthcare Cost and Utilization Project [database online].Rockville, MD: Agency for Healthcare Research; 2015

Conrad C, Trüeb RM. Pyoderma gangrenosum. Pyoderma gangraenosum. J Dtsch Dermatol Ges. 2005; 3:(5)334-342 https://doi.org/10.1111/j.1610-0387.2005.05022.x

Vidal D, Puig L, Gilaberte M, Alomar A. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat. 2004; 15:(3)146-152 https://doi.org/10.1080/09546630410031909

Stolman LP, Rosenthal D, Yaworsky R, Horan F. Pyoderma gangrenosum and rheumatoid arthritis. Arch Dermatol. 1975; 111:(8)1020-1023 https://doi.org/10.1001/archderm.1975.01630200080009

US Census Bureau. 2010 census data shows America's diversity. https://www.census.gov/newsroom/releases/archives/2010_census/cb11-cn125.html (accessed 12 December 2017)

Teagle A, Hargest R. Management of pyoderma gangrenosum. J R Soc Med. 2014; 107:(6)228-236 https://doi.org/10.1177/0141076814534407

Saracino A, Kelly R, Liew D, Chong A. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol. 2011; 52:(3)218-221 https://doi.org/10.1111/j.1440-0960.2011.00750.x

Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012; 132:(9)2166-2170 https://doi.org/10.1038/jid.2012.130

Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases

02 April 2018
7 min read
Volume 2 · Issue 2

Abstract

Objective:

Pyoderma gangrenosum is a rare, neutrophil-mediated, auto-inflammatory dermatosis. This condition has clinical features analogous to infectious processes and must be quickly diagnosed to be properly treated. The purpose of this study was to characterise relevant clinical features associated with pyoderma gangrenosum based on a large inpatient cohort.

Method:

The National Inpatient Sample (US) was used to identify patients with the diagnosis of pyoderma gangrenosum using ICD-9 diagnosis code 686.01, during the years 2008–2010. Data was collected on demographics, associated diagnoses, treatments and outcomes. Data analysis was performed using SAS 9.3 software.

Results:

A total of 2,273 adult patients were identified with pyoderma gangrenosum. Mean age was 56 years; 66.4% were female; 71.1% were Caucasian. Pyoderma gangrenosum was the primary diagnosis in 22.6% of patients, followed by cellulitis (9.4%), inflammatory bowel disease (IBD) (6.9%), wound/ulcer (5.4%), sepsis (4.7%), and postoperative infection/complication (2.7%). The most common procedures performed were wound debridement (5.3%), skin biopsy (5.1%), esophagogastroduodenoscopy (2%), large bowel biopsy (1.9%), and incision and drainage (1.1%). A total of 74 patients (3.2%) died during hospitalisation.

Conclusion:

Pyoderma gangrenosum is a serious skin condition, frequently associated with systemic disease, and often confused with other skin pathergies. Pyoderma gangrenosum should be considered when evaluating patients with ulcers, wounds, and post-operative complications. A high index of suspicion is necessary for early and accurate diagnosis and prompt treatment.

Pyoderma gangrenosum (PG) is a rare, auto-inflammatory skin condition characterised by pustules that progress to sterile, ulcerative cutaneous lesions. Most eruptions are spontaneous and occur in association with hematologic, rheumatologic, or gastrointestinal disease. However, lesions also develop at traumatic and surgical sites.1 PG was first described in 1916 by Louis Brocq in five patients with necrotic, rapidly-progressive ulcers with a cliff-like ridge at the border.2 The term ‘pyoderma gangrenosum’ was coined by Brusting et al. in 1930, who believed the condition to be a form of cutaneous gangrene caused by disseminated streptococcal infection.3 Though still poorly understood, the aetiology of PG is currently hypothesised to be autoinflammatory, rather than infectious.4

Diagnosis of PG can be difficult because its presentation is similar to other infectious and inflammatory processes, including wound infection, hidradenitis suppurativa, cutaneous malignancy, antiphospholipid syndrome, Bechet's disease, ecthyma gangrenosum, leukocytoclastic vasculitis, and Sweet's syndrome.5,6,7 PG can progress rapidly, does not respond to antibiotic therapy, and is exacerbated by surgical debridement. Prompt diagnosis is critical to avoid serious morbidity.8

Register now to continue reading

Thank you for visiting Wound Central and reading some of our peer-reviewed resources for wound care professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Access to clinical or professional articles

  • New content and clinical updates each month